Abiy Agiro, PhD

Director, US Evidence
AstraZeneca

Poster(s):

• (37) Healthcare Costs and Delays in Treatment Escalation in Hypertension Patients in the United States: Results from the BREAKTHROUGH Real-World Study
  Wednesday, October 29, 2025